Press Releases

Incyte announced that the Phase 3 RUXCOVID study evaluating the safety and efficacy of ruxolitinib (Jakafi®), a JAK1/JAK2 inhibitor, plus standard-of-care (SoC) as a treatment for patients 12 years and older with COVID-19 associated cytokine storm did not meet...

Global contract development and manufacturing organisation (CDMO), Recipharm, has announced an investment and capacity expansion at its facility in Israel. This investment will support customers’ growing demand for cGMP clinical supply of active pharma ingredients (API) and intermediates and...

Cryoport, Inc., a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced a three-year agreement with the Colorado Center for Reproductive Medicine ("CCRM"), a global pioneer in fertility science, research and advancement. Under the terms...

Roche announced a partnership with Moderna Inc. to utilise the Elecsys® Anti-SARS-CoV-2 S antibody test in Moderna’s mRNA-1273 vaccine research trials. This will facilitate the quantitative measurement of SARS-CoV-2 antibodies and help to establish a correlation between vaccine-induced protection...

HALIX B.V. signed an agreement with AstraZeneca AB for large-scale commercial drug substance manufacture of AZD1222, the adenovirus vector-based COVID-19 vaccine. Under the agreement, HALIX will provide commercial manufacturing of drug substance at its state-of-the-art cGMP facility at the Leiden...

The Vaccines Manufacturing and Innovation Centre in Oxfordshire (VMIC), UK has selected Lonza’s MODA-EM™ Solution to digitize its Microbiology Quality Control operations. The MODA EM™ Platform will form a vital part of ongoing work that will support the...

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it is investing $10 million in isolator capabilities at its sites in Malvern,...